BioSpace News Archive

Business

Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced first quarter 2022 financial results and provided a business update.

May 11, 2022
·
11 min read
Business

ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced its first quarter 2022 financial results and provided a business update.

May 11, 2022
·
16 min read
Business

Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business UpdateConference call and live webcast at 4:30 p.m. ET today

Onconova Therapeutics, Inc. announced financial results for the three months ended March 31, 2022, and provided a business update.

May 11, 2022
·
8 min read
Business

Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics, today reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.

May 11, 2022
·
8 min read
Business

Minerva Surgical Reports First Quarter 2022 Financial Results

Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today reported first quarter financial results for the period ended March 31, 2022.

May 11, 2022
·
11 min read
Biotech Bay

Nurix Therapeutics Announces Participation in the 2022 RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics, Inc. announced that Arthur T. Sands, M.D., Ph.D., Nurix’s president and chief executive officer, will participate in a fireside chat at the 2022 RBC Capital Markets Global Healthcare Conference on Wednesday, May 18th, 2022 at 11:00 a.m. ET.

May 11, 2022
·
1 min read
Business

Exagen Inc. Reports First Quarter 2022 Results

Exagen Inc., a leading provider of autoimmune testing solutions, reported financial results for the quarter ended March 31, 2022.

May 11, 2022
·
9 min read
Biotech Beach

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

Exagen Inc., a leading provider of autoimmune testing solutions, announced that Medicare Administrative Contractor Noridian has provided pricing for AVISE® Lupus.

May 11, 2022
·
4 min read
Business

Teknova Reports First Quarter 2022 Financial Results

Alpha Teknova, Inc., a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, announced financial results for the first quarter ended March 31, 2022.

May 11, 2022
·
12 min read
Genetown

Myrtelle Inc. Announces Expansion of Its Pipeline with a Novel Gene Therapy Program for Pelizaeus-Merzbacher Disease (PMD)

Myrtelle Inc. announced the launch of a new research program for Pelizaeus-Merzbacher Disease, an X-linked recessive brain disorder of oligodendrocytes that disrupts myelin production.

May 11, 2022
·
5 min read